Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
Mofenson LM, Pozniak AL, Wambui J, Raizes E, Ciaranello A, Clayden P, Ehrenkranz P, Fakoya A, Hill A, Khoo S, Mahaka I, Modi S, Moore C, Phillips A, Siberry G, Sikwese K, Thorne C, Watts HD, Doherty M, Ford NP.
Mofenson LM, et al.
J Int AIDS Soc. 2019 Jul;22(7):e25352. doi: 10.1002/jia2.25352.
J Int AIDS Soc. 2019.
PMID: 31298496
Free PMC article.